DAFNA Capital Management as of June 30, 2016
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 94 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NxStage Medical | 6.1 | $7.7M | 357k | 21.68 | |
| AtriCure (ATRC) | 5.8 | $7.3M | 514k | 14.13 | |
| Vitae Pharmaceuticals | 5.7 | $7.1M | 660k | 10.79 | |
| Dermira | 4.5 | $5.7M | 194k | 29.25 | |
| Abbvie (ABBV) | 3.8 | $4.7M | 76k | 61.91 | |
| Rigel Pharmaceuticals (RIGL) | 3.3 | $4.1M | 1.8M | 2.23 | |
| Alder Biopharmaceuticals | 3.3 | $4.1M | 165k | 24.97 | |
| Novavax | 3.2 | $4.0M | 550k | 7.27 | |
| Cynapsus Therapeutics | 2.9 | $3.7M | 222k | 16.58 | |
| Galapagos Nv- (GLPG) | 2.8 | $3.5M | 64k | 55.47 | |
| Neurocrine Biosciences (NBIX) | 2.7 | $3.4M | 76k | 45.46 | |
| Aerie Pharmaceuticals | 2.2 | $2.8M | 161k | 17.60 | |
| Insulet Corporation (PODD) | 2.2 | $2.8M | 92k | 30.24 | |
| Tesaro | 2.0 | $2.5M | 30k | 84.07 | |
| Tandem Diabetes Care | 1.9 | $2.4M | 313k | 7.54 | |
| Applied Genetic Technol Corp C | 1.9 | $2.4M | 167k | 14.13 | |
| Loxo Oncology | 1.9 | $2.4M | 102k | 23.18 | |
| Insulet Corp note 2.000% 6/1 | 1.8 | $2.3M | 2.4M | 0.95 | |
| Immunomedics | 1.5 | $1.9M | 815k | 2.32 | |
| Achillion Pharmaceuticals | 1.5 | $1.8M | 237k | 7.80 | |
| Aeglea Biotherapeutics | 1.4 | $1.7M | 350k | 4.86 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.3 | $1.7M | 2.5M | 0.66 | |
| Biotelemetry | 1.3 | $1.6M | 100k | 16.30 | |
| BioSpecifics Technologies | 1.3 | $1.6M | 40k | 39.95 | |
| Zogenix | 1.3 | $1.6M | 198k | 8.05 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.2 | $1.5M | 6.0k | 257.33 | |
| Spectranetics Corporation | 1.2 | $1.5M | 80k | 18.71 | |
| Macrogenics (MGNX) | 1.2 | $1.5M | 54k | 26.99 | |
| Cytokinetics (CYTK) | 1.1 | $1.4M | 150k | 9.49 | |
| Derma Sciences | 1.1 | $1.4M | 354k | 3.94 | |
| Radius Health | 1.1 | $1.4M | 38k | 36.76 | |
| Stereotaxis (STXS) | 1.1 | $1.3M | 1.4M | 0.98 | |
| Cara Therapeutics (CARA) | 1.0 | $1.3M | 267k | 4.81 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $1.3M | 214k | 5.90 | |
| Regulus Therapeutics | 1.0 | $1.2M | 422k | 2.89 | |
| Foamix Pharmaceuticals | 1.0 | $1.2M | 193k | 6.35 | |
| Synergy Pharmaceuticals | 1.0 | $1.2M | 320k | 3.80 | |
| Corbus Pharmaceuticals Hldgs | 0.9 | $1.2M | 400k | 2.99 | |
| Achaogen | 0.9 | $1.2M | 314k | 3.79 | |
| Uniqure Nv (QURE) | 0.9 | $1.2M | 159k | 7.37 | |
| Johnson & Johnson (JNJ) | 0.9 | $1.1M | 9.4k | 121.28 | |
| Ldr Hldg | 0.9 | $1.1M | 30k | 36.97 | |
| Windtree Therapeutics | 0.8 | $1.0M | 533k | 1.93 | |
| Novadaq Technologies | 0.8 | $1.0M | 102k | 9.84 | |
| Exactech | 0.7 | $846k | 32k | 26.74 | |
| Minerva Neurosciences | 0.7 | $818k | 80k | 10.21 | |
| Essa Pharma | 0.6 | $810k | 203k | 4.00 | |
| Geron Corporation (GERN) | 0.6 | $764k | 285k | 2.68 | |
| Concert Pharmaceuticals I equity | 0.6 | $752k | 67k | 11.23 | |
| Ascendis Pharma A S (ASND) | 0.6 | $707k | 53k | 13.28 | |
| Syneron Medical Ltd ord | 0.5 | $661k | 86k | 7.69 | |
| Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.5 | $618k | 600k | 1.03 | |
| Beigene (BGNE) | 0.5 | $596k | 20k | 29.80 | |
| Scynexis | 0.5 | $579k | 267k | 2.17 | |
| Cynapsus Therapeutics | 0.5 | $564k | 34k | 16.59 | |
| Intec Pharma | 0.4 | $549k | 119k | 4.60 | |
| Innocoll Hldgs | 0.4 | $551k | 100k | 5.51 | |
| Masimo Corporation (MASI) | 0.4 | $525k | 10k | 52.50 | |
| Targacept Inc Conv Dtd convertible | 0.4 | $531k | 531k | 1.00 | |
| Bluebird Bio (BLUE) | 0.4 | $519k | 12k | 43.25 | |
| Tetraphase Pharmaceuticals | 0.3 | $446k | 104k | 4.30 | |
| Adverum Biotechnologies | 0.3 | $444k | 141k | 3.16 | |
| Abeona Therapeutics | 0.3 | $429k | 182k | 2.36 | |
| Vtv Therapeutics Inc- Cl A | 0.3 | $423k | 73k | 5.79 | |
| Pieris Pharmaceuticals (PIRS) | 0.3 | $360k | 223k | 1.61 | |
| Neos Therapeutics | 0.3 | $361k | 39k | 9.29 | |
| Dicerna Pharmaceuticals | 0.3 | $358k | 119k | 3.00 | |
| Cogentix Medical | 0.3 | $339k | 353k | 0.96 | |
| Ardelyx (ARDX) | 0.2 | $262k | 30k | 8.73 | |
| Arbutus Biopharma (ABUS) | 0.2 | $261k | 75k | 3.48 | |
| AVEO Pharmaceuticals | 0.2 | $249k | 259k | 0.96 | |
| Nemus Bioscience | 0.2 | $251k | 512k | 0.49 | |
| Dextera Surgical | 0.2 | $253k | 140k | 1.80 | |
| Neuroderm Ltd F | 0.2 | $234k | 14k | 16.23 | |
| Sunesis Pharmaceuticals | 0.2 | $233k | 423k | 0.55 | |
| Glycomimetics (GLYC) | 0.2 | $204k | 28k | 7.29 | |
| Tenax Therapeutics | 0.2 | $204k | 80k | 2.57 | |
| Adaptimmune Therapeutics (ADAP) | 0.2 | $203k | 25k | 8.13 | |
| Blueprint Medicines (BPMC) | 0.2 | $205k | 10k | 20.30 | |
| Akebia Therapeutics (AKBA) | 0.1 | $185k | 25k | 7.49 | |
| Vistagen Therapeutics | 0.1 | $183k | 47k | 3.90 | |
| Cascadian Therapeutics | 0.1 | $165k | 175k | 0.94 | |
| Check Cap | 0.1 | $123k | 88k | 1.39 | |
| Marinus Pharmaceuticals | 0.1 | $115k | 90k | 1.27 | |
| Catalyst Biosciences | 0.1 | $108k | 71k | 1.52 | |
| Cel-sci | 0.1 | $59k | 128k | 0.46 | |
| Nivalis Therapeutics | 0.1 | $69k | 15k | 4.60 | |
| Antares Pharma | 0.0 | $47k | 45k | 1.04 | |
| Genvec | 0.0 | $55k | 96k | 0.57 | |
| Aldeyra Therapeutics (ALDX) | 0.0 | $14k | 2.5k | 5.60 | |
| Enteromedics | 0.0 | $10k | 33k | 0.30 | |
| Check Cap Ltd w exp 02/28/202 | 0.0 | $4.8k | 54k | 0.09 | |
| Akari Therapeutics | 0.0 | $6.0k | 458.00 | 13.10 | |
| Onconova Therapeutics | 0.0 | $1.0k | 200.00 | 5.00 |
